Atlas Trials

The Expected Advantage of Administering Prophylactic Antibiotics Using Target- Concentration Controlled Infusion

Clinical trial NCT05253339 · COMPLETED

Trial details

NCT number
NCT05253339
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Anti-bacterial AgentsPharmacokineticsGeneral Surgery
Start date
2022-04-04
Primary completion
2025-08-28
Enrollment
2494

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.